Krishna Institute of Medical Sciences · NSE: KIMS · BSE: 543308
Q2 FY25 results · Jul–Sep 2024
Krishna Institute of Medical Sciences reported revenue from operations of ₹777.30 crore (up 19.1% from Q2 FY24) and net profit of ₹120.70 crore (up 19.2% from Q2 FY24) for Q2 FY25 (Jul–Sep 2024), on a consolidated basis.
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 777.30 | 652.48 | +19.1% | 688.40 | +12.9% |
| Other income | 5.00 | 2.88 | +73.5% | 4.60 | +8.7% |
| Total income | 782.30 | 655.36 | +19.4% | 693.00 | +12.9% |
| Profit before tax | 162.20 | 138.62 | +17.0% | 127.10 | +27.6% |
| Net profit for the period | 120.70 | 101.29 | +19.2% | 95.20 | +26.8% |
| Attributable to shareholders of the company | 107.40 | 92.18 | +16.5% | 86.60 | +24.0% |
| EPS, basic (₹) | 2.68 | 11.50 | not comparable | 10.82 | not comparable |
| Net margin (%) | 15.5 | 15.5 | 13.8 |
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 363.30 | 316.25 | +14.9% | 327.40 | +11.0% |
| Other income | 6.60 | 3.57 | +85.0% | 5.30 | +24.5% |
| Total income | 369.90 | 319.81 | +15.7% | 332.70 | +11.2% |
| Profit before tax | 99.10 | 89.02 | +11.3% | 81.60 | +21.4% |
| Net profit for the period | 72.20 | 66.16 | +9.1% | 60.70 | +18.9% |
| EPS, basic (₹) | 1.80 | 8.27 | not comparable | 7.58 | not comparable |
| Net margin (%) | 19.9 | 20.9 | 18.5 |
Consolidated
- Filed with BSE
- 09 Nov 2024, 19:42 IST
- Board meeting
- 09 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 09 Nov 2024, 19:42 IST
- Board meeting
- 09 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE